跳至主要内容
临床试验/IRCT20200720048146N1
IRCT20200720048146N1尚未招募1 期

Comparison of sedation effect of midazolam and muscle haloperidol in treatment of agitation of patients

Zahedan University of Medical Sciences0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 years 至 60 years(—)
性别
All

入选标准

  • Includes age 15 to 60 years
  • Score above 28 on the agitation measurement scale

排除标准

  • Patient dissatisfaction (or legal partner)
  • Unstable vital signs (blood pressure less than 90 mm Hg, heart rate below 60 and above 120 beats per minute, oxygen saturation level below 90%, level of consciousness less than agitation)
  • History of heart disease and liver and kidney failure
  • Pregnancy and lactation
  • The patient is very restless and has the potential to harm himself and others and can not wait for a response to intramuscular injection of the drug.
  • Poisoning with an unknown drug
  • A history of active seizures requires medication
  • Myasthenia Gravis
  • Bone marrow suppression
  • Patients with coagulation disorders such as hemophilia in whom intramuscular injection is contraindicated
  • Thyrotoxicosis
  • Hypersensitivity to midazolam or haloperidol

研究者

发起方
Zahedan University of Medical Sciences

相似试验